HIGHLIGHTS
- who: Robert Rosenheck from the D, Campbell Ave, West Haven, CT, USA Boston University School of Medicine, Boston, MA, USA have published the Article: Can multisite clinical trial results change clinical practice? Use of long-acting injectable risperidone nationally in the Veterans Health Administration, in the Journal: (JOURNAL)
- what: Schizophrenia, the focus of this study, is perhaps the most disabling of psychiatric conditions affecting approximately 1% of all adults and almost 100,000 VA patients each year at a cost of thousands of dollars per patient .
- how: The authors hypothesized that in the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.